Marylyn Donahue, Special Projects Editor

The good news is that as the industry changes its sales force model, the need for meetings will increase

Agency Confidential interrogated 21 executives at top healthcare agencies to find out the skinny on what is really happening with pharma marketing and advertising at this dire time for the industry. Here is the report.

Pharma friendless on Facebook | DTC ad spending flat | Rate of healthcare marketing and advertising falls | Consumers chose food over meds | Some see light at tunnel's end

Neither Washington nor the public has any patience for executives playing golf at fancy resorts. It doesn't matter if they are there attending a conference, or that important business is often conducted on the green, or that the Battle of Waterloo was won on the playing fields of Eton.

Product managers are key figures as maintaining a winning portfolio becomes a lot harder, more complex, and vastly more important

Is a phoenix beginning to rise from this year's layoffs, expiring patents, and regulatory setbacks? Ask the consultants...

Drugs are being mentioned more and more on TV shows. Is it just part of the script—or promotion on the part of the industry? If so, should it be regulated?

Between Congress, the courts, and consumers, DTC is having a rough year. Pharma marketers are now being pressured to delay direct-to-consumer advertising for six months. Is it time to pay more attention to educating doctors and patients?

Dr. House, the lead character in TV's hit medical drama, House, is a high-prescribing diagnostician whose drug treatments can as easily kill or cure a patient. Can this be marketing?